home / stock / rytm / rytm news

RYTM News and Press, Rhythm Pharmaceuticals Inc. From 02/21/24

Stock Information
Company Name: Rhythm Pharmaceuticals Inc.
Stock Symbol: RYTM
Market: NASDAQ
Website: rhythmtx.com
Menu
RYTM RYTM Quote RYTM Short RYTM News RYTM Articles RYTM Message Board
Get RYTM Alerts

News, Short Squeeze, Breakout and More Instantly...
RYTM - Notable earnings before Thursday's open

2024-02-21 09:42:51 ET Major earnings expected before the bell on Thursday include: Dominion Energy ( D ) Iron Mountain ( IRM ) Moderna ( MRNA ) Newmont ( NEM ) Nikola ( NKLA ) Read the full article on Seeking Alpha For further details...
RYTM - Rhythm Pharmaceuticals Announces Positive Reimbursement Decision in Italy for IMCIVREE® (setmelanotide) for the Treatment of Obesity and Control of Hunger in Bardet-Biedl Syndrome

BOSTON, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families living with rare neuroendocrine diseases, today announced that the Italian Medicine Agency (A...

RYTM - Rhythm Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, February 22, 2024

BOSTON, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families living with rare neuroendocrine diseases, today announced that it will host a live conference...

RYTM - (RYTM) Investment Report

2024-01-21 22:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
RYTM - J.P. Morgan event in spotlight as biotech M&A, obesity frenzy, AI pick up

2024-01-07 12:00:45 ET More on AbbVie, Bristol-Myers, etc. AbbVie: Still Expensive Despite The Great M&A Acumen Bristol-Myers Squibb Company (BMY) Goldman Sachs Healthcare C-Suite Unscripted Conference (Transcript) Merck & Co., Inc. (MRK) Goldman Sachs Health...

RYTM - Rhythm completes screening for Phase 3 anti-obesity study

2024-01-04 10:48:31 ET More on Rhythm Pharmaceuticals Rhythm Pharmaceuticals: Major Catalysts Due For Weight Loss Specialist Rhythm Pharmaceuticals, Inc. (RYTM) Q3 2023 Earnings Call Transcript Rhythm Pharmaceuticals, Inc. 2023 Q3 - Results - Earnings Call Presentati...

RYTM - Rhythm acquires rights to Phase 2 anti-obesity drug from LG Chem

2024-01-04 09:51:10 ET More on Rhythm Pharmaceuticals Rhythm Pharmaceuticals: Major Catalysts Due For Weight Loss Specialist Rhythm Pharmaceuticals, Inc. (RYTM) Q3 2023 Earnings Call Transcript Rhythm Pharmaceuticals, Inc. 2023 Q3 - Results - Earnings Call Presentati...
RYTM - Rhythm Pharmaceuticals and LG Chem Life Sciences Enter Agreement for Rhythm to Acquire Global Rights to Oral MC4R Agonist LB54640

-- LB54640 has shown targeted effect on MC4 receptor without hyperpigmentation -- -- Rhythm to advance LB54640 in two Phase 2 clinical trials -- BOSTON, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company...

RYTM - Rhythm Pharmaceuticals Announces Completion of Screening for Enrollment in Setmelanotide Phase 3 Hypothalamic Obesity Trial and Additional Updates

-- Phase 3 hypothalamic obesity top-line data expected in 1H2025 -- -- Positive reimbursement decision achieved for IMCIVREE ® (setmelanotide) to treat patients with Bardet-Biedl syndrome and POMC/LEPR deficiencies in Spain -- -- IND application for RM-7...

RYTM - Biotech Bonanza: 2024 Biotech Outlook As The Fed Turns Dovish

2024-01-03 07:00:00 ET Summary The biotech industry experienced a challenging year in 2023 due to a rising 10-year Treasury yield. In 2024, the 10-year yield should favorably support biotech stocks. Promising advancements in weight loss drugs, neuroscience, oncology, and gene ...
Previous 10 Next 10